Healthy Returns: AbbVie is the newest potential weight loss drug market player
AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS conference gets underway in Vegas.
Who carries and uses naloxone in the US? Study addresses lack of nationwide data
A new USC-led study provides the first nationwide picture of who knows about, carries, and uses naloxone to reverse deadly ...
WBOI4d
Alzheimer's was taking her memory, so she started taking a new drug
Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.